Revenue | ₹1.80Cr |
Net Profits | ₹0.33Cr |
Net Profit Margins | 18.33% |
Shree Ganesh Biotech India Ltd’s revenue fell -54.08% since last year same period to ₹1.80Cr in the Q1 2025-2026. On a quarterly growth basis, Shree Ganesh Biotech India Ltd has generated -48.13% fall in its revenue since last 3-months.
Shree Ganesh Biotech India Ltd’s net profit jumped 37.5% since last year same period to ₹0.33Cr in the Q1 2025-2026. On a quarterly growth basis, Shree Ganesh Biotech India Ltd has generated 134.74% jump in its net profits since last 3-months.
Shree Ganesh Biotech India Ltd’s net profit margin jumped 199.44% since last year same period to 18.33% in the Q1 2025-2026. On a quarterly growth basis, Shree Ganesh Biotech India Ltd has generated 166.96% jumped in its net profit margins since last 3-months.
The revenue for Shree Ganesh Biotech India Ltd in the Q1 results 2025 was ₹1.80Cr.
The net profit for Shree Ganesh Biotech India Ltd in the Q1 results 2025 was ₹0.33Cr.
The net profit margin for Shree Ganesh Biotech India Ltd in the Q1 results 2025 was 18.33%.
The revenue for Shree Ganesh Biotech India Ltd in the Q1 results 2024 was ₹3.92Cr.
The net profit for Shree Ganesh Biotech India Ltd in the Q1 results 2024 was ₹0.24Cr.
The net profit margin for Shree Ganesh Biotech India Ltd in the Q1 results 2024 was 6.12%.